BTMD
bioteDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The constructive read is that management maintained full-year revenue and adjusted EBITDA targets despite a recall-related Q1 disruption, while reiterating expected second-half procedure growth and continued sales-force build-out. That supports a recovery setup if supply continuity improves quickly.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Biote disclosed that Asteria Health and related outsourcing facilities have received FDA warning-letter or Form 483 scrutiny, and the January 2026 voluntary recall followed FDA engagement, leaving regulatory and supplier risk elevated. [#10-K-2026-03-13]
Momentum
31
Value
72
Sentiment
24
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.90 · Bull $3.00 · Bear $1.20
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $2.73
Why
Momentum31 · Δ7d -
Value72 · Δ7d -0.2
Sentiment24 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
31
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
72
39% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.3
Sentiment
24
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 31.4 / Value 72.0 / Sentiment 24.4
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$93.58M
Beta
1.16
Shares Out
30.33M
P/E (TTM)
2.9
P/S (TTM)
0.58
P/FCF (TTM)
3.28
Rev YoY
-8.3%
EPS YoY
-82.9%
Gross Margin
+68.5%
Op Margin
+16.1%
Net Debt
$104.3M
Current Ratio
1.29
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology